Page 2 – Swiss Vaccine Research Institute

Fischinger, S., Cizmeci, D., Deng, D., Grant, S. P., Frahm, N., McElrath, J., Fuchs, J., Bart, P. A., Pantaleo, G., Keefer, M., W, O. H., Rouphael, N., Churchyard, G., Moodie, Z., Donastorg, Y., Streeck, H., and Alter, G.

Nov 29, 2021 | Publications

Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials

Fenwick, C., Turelli, P., Perez, L., Pellaton, C., Esteves-Leuenberger, L., Farina, A., Campos, J., Lana, E., Fiscalini, F., Raclot, C., Pojer, F., Lau, K., Demurtas, D., Descatoire, M., Joo, V. S., Foglierini, M., Noto, A., Abdelnabi, R., Foo, C. S., Vangeel, L., Neyts, J., Du, W., Bosch, B. J., Veldman, G., Leyssen, P., Thiel, V., LeGrand, R., Levy, Y., Trono, D., and Pantaleo, G.

Oct 12, 2021 | Publications

A highly potent antibody effective against SARS-CoV-2 variants of concern

Obeid M., Fenwick C., Pantaleo G.

Sep 3, 2021 | Publications

Reactivation of IgA vasculitis after COVID-19 vaccination

Marlin, R., Godot, V., Cardinaud, S., Galhaut, M., Coleon, S., Zurawski, S., Dereuddre-Bosquet, N., Cavarelli, M., Gallouet, A. S., Maisonnasse, P., Dupaty, L., Fenwick, C., Naninck, T., Lemaitre, J., Gomez-Pacheco, M., Kahlaoui, N., Contreras, V., Relouzat, F., Fang, R. H. T., Wang, Z., Ellis, J., 3rd, Chapon, C., Centlivre, M., Wiedemann, A., Lacabaratz, C., Surenaud, M., Szurgot, I., Liljestrom, P., Planas, D., Bruel, T., Schwartz, O., Werf, S. V., Pantaleo, G., Prague, M., Thiebaut, R., Zurawski, G., Levy, Y., and Grand, R. L.

Sep 1, 2021 | Publications

Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques

Perreau, M., Suffiotti, M., Marques-Vidal, P., Wiedemann, A., Levy, Y., Laouenan, C., Ghosn, J., Fenwick, C., Comte, D., Roger, T., Regina, J., Vollenweider, P., Waeber, G., Oddo, M., Calandra, T., and Pantaleo, G.

Aug 9, 2021 | Publications

The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients

Fenwick, C., Turelli, P., Pellaton, C., Farina, A., Campos, J., Raclot, C., Pojer, F., Cagno, V., Nussle, S. G., D’Acremont, V., Fehr, J., Puhan, M., Pantaleo, G., and Trono, D.

Aug 4, 2021 | Publications

A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma

Levy, Y., Wiedemann, A., Hejblum, B. P., Durand, M., Lefebvre, C., Surenaud, M., Lacabaratz, C., Perreau, M., Foucat, E., Dechenaud, M., Tisserand, P., Blengio, F., Hivert, B., Gauthier, M., Cervantes-Gonzalez, M., Bachelet, D., Laouenan, C., Bouadma, L., Timsit, J. F., Yazdanpanah, Y., Pantaleo, G., Hocini, H., Thiebaut, R., and French, C. c. s. g.

Jul 23, 2021 | Publications

CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death

Meylan S, Dafni U, Lamoth F, Tsourti Z, Lobritz MA, Regina J, Bressin P, Senn L, Grandbastien B, Andre C., Fenwick C., D’Acremont V., Croxatto A., Guilleret I., Greub G., Manuel O., Calandra T., Pantaleo G., Lazor-Blanchet C.; COVID-19 MISS group

Jul 5, 2021 | Publications

SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study

Deng, Y., Chatterjee, B., Zens, K., Zdimerova, H., Muller, A., Schuhmachers, P., Ligeon, L. A., Bongiovanni, A., Capaul, R., Zbinden, A., Holler, A., Stauss, H., Hammerschmidt, W., and Munz, C.

Jun 10, 2021 | Publications

CD27 is required for protective lytic EBV antigen-specific CD8+ T-cell expansion

Filippidis, P., van Ouwenaller, F., Cerutti, A., Geiger-Jacquod, A., Sempoux, C., Pantaleo, G., Moradpour, D., and Lamoth, F.

May 18, 2021 | Publications

Case Report: SARS-CoV-2 as an unexpected causal agent of predominant febrile hepatitis

« Older Entries

Next Entries »